Jeffrey Larson

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors”.

Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2920

N/A

0.977DataRank · unranked

49 citations

David Vining, Sukeshi Patel Arora, Sofia de Achaval, Jeffrey Larson, John Kauh +6 more

Does the Presence of Lung Incidental Findings on Low-Dose CT for Lung Cancer Screening Lead to Additional Testing?

CHEST Pulmonary(2024)10.1016/j.chpulm.2024.100096

N/A

0DataRank · unranked

0 citations

Abbie Begnaud, Rebecca Freese, Jeffrey Larson